What are the best treatments for Marshall syndrome - PFAPA?

TL;DR: Treatment for Marshall syndrome (PFAPA) primarily focuses on symptom management during episodes using short-course corticosteroids or cimetidine, with tonsillectomy serving as a definitive surgical option for many patients. While there is no single cure, most children see the condition resolve spontaneously over time, and a multidisciplinary care team is essential for tailoring these interventions to the individual child.

What are the first-line medical treatments for Marshall syndrome (PFAPA)?

The management of Marshall syndrome (PFAPA)—which stands for Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis—is primarily supportive, as the condition is self-limiting. The most common first-line pharmacological intervention is a single, low-dose oral corticosteroid, such as prednisone or prednisolone. This often leads to a rapid resolution of fever and symptoms within hours; however, clinicians note that this can sometimes shorten the interval between subsequent episodes. For patients who experience frequent flares, cimetidine (Tagamet)—an H2-receptor antagonist—is often prescribed as a prophylactic daily medication, which may reduce the frequency and severity of episodes in a subset of patients.

When is surgery considered for Marshall syndrome (PFAPA)?

For children who do not respond well to medical management or whose quality of life is significantly impacted by the recurrent nature of Marshall syndrome (PFAPA), a tonsillectomy (with or without adenoidectomy) is often considered. Clinical evidence suggests that this surgical intervention is highly effective, with a significant majority of patients experiencing long-term remission following the procedure. Because Marshall syndrome (PFAPA) symptoms are localized to the throat and lymph nodes, removing the tonsillar tissue often eliminates the trigger for the inflammatory response.

Which specialists should be on the care team for Marshall syndrome (PFAPA)?

Because Marshall syndrome (PFAPA) affects multiple systems and impacts a child’s developmental and social life, a multidisciplinary approach is recommended. A well-rounded care team typically includes:

• Pediatric Rheumatologist: To confirm the diagnosis and rule out other periodic fever syndromes or autoinflammatory conditions.


• Pediatric Otolaryngologist (ENT): To evaluate the tonsils and adenoids and manage surgical options.


• Pediatrician or Primary Care Physician: To coordinate ongoing monitoring of growth and development.


• Clinical Psychologist: To support the child and family in managing the stress, school absences, and anxiety associated with chronic, recurring illness.

How does treatment effectiveness vary between patients?

Treatment success for Marshall syndrome (PFAPA) is highly individual. While some children respond dramatically to corticosteroids, others may experience "rebound" fevers or shortened flare cycles. Similarly, while many children achieve full remission after a tonsillectomy, a small percentage may continue to experience symptoms. It is important to note that the DiseaseMaps.org community, which includes 7 members sharing their experiences with Marshall syndrome (PFAPA), highlights that the "best" treatment is often a process of trial and error guided by a specialist.

Are there emerging treatments or research updates?

Research into Marshall syndrome (PFAPA) is ongoing, focusing on better understanding the underlying immune dysregulation. Current studies are investigating the role of interleukin-1 (IL-1) inhibitors for refractory cases, though these are typically reserved for patients who do not respond to standard protocols. Because Marshall syndrome (PFAPA) is a rare condition, clinical trials are often small; caregivers are encouraged to consult with academic medical centers that specialize in autoinflammatory diseases for the most current data.

Next steps

• Consult with a pediatric rheumatologist to ensure an accurate diagnosis and rule out genetic autoinflammatory disorders.


• Keep a detailed "fever diary" tracking the duration, frequency, and specific symptoms of each episode to share with your medical team.


• Connect with the community at DiseaseMaps.org to share experiences with other families managing this condition.


• Discuss the potential risks and benefits of a tonsillectomy with an ENT specialist if your child’s quality of life is significantly impacted.

Medical disclaimer: Treatment for Marshall syndrome (PFAPA) must be personalized by your child's medical team; never adjust medications or pursue surgical options without professional clinical guidance.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Information on PFAPA syndrome.


• Orphanet: Clinical database for rare diseases and orphan drugs.


• OMIM (Online Mendelian Inheritance in Man): Genetic and clinical perspectives on periodic fever syndromes.


• American College of Rheumatology: Guidelines for managing autoinflammatory conditions in pediatric populations.